0000914475-13-000022.txt : 20130401
0000914475-13-000022.hdr.sgml : 20130401
20130401172642
ACCESSION NUMBER: 0000914475-13-000022
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130328
FILED AS OF DATE: 20130401
DATE AS OF CHANGE: 20130401
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEUROCRINE BIOSCIENCES INC
CENTRAL INDEX KEY: 0000914475
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330525145
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12780 EL CAMINO REAL
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 617-7600
MAIL ADDRESS:
STREET 1: 12780 EL CAMINO REAL
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MITCHELL W THOMAS
CENTRAL INDEX KEY: 0001214352
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-22705
FILM NUMBER: 13732477
MAIL ADDRESS:
STREET 1: 48030 PASO TIEMPO LN
CITY: LA QUINTA
STATE: CA
ZIP: 92253
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2013-03-28
0000914475
NEUROCRINE BIOSCIENCES INC
NBIX
0001214352
MITCHELL W THOMAS
12780 EL CAMINO REAL
SAN DIEGO
CA
92130
1
0
0
0
Common Stock
2013-03-28
4
M
0
12000
10.60
A
13000
D
Common Stock
2013-03-28
4
F
0
10469
12.15
D
2531
D
Stock Option
10.60
2013-03-28
4
M
0
12000
0
D
2008-06-30
2013-06-30
Common Stock
12000
0
D
The share issuance reported on Table I reflects shares issued upon the exercise of options granted on June 30, 2006, which, if unexercised, would have expired on June 30, 2013. The option exercises are reported on Table II. These option exercises were pursuant to a net issuance arrangement effected under the issuer's equity incentive plan. The number of shares issued pursuant to the net issuance arrangement was calculated as follows: the option exercise price ($10.60) was subtracted from the March 28, 2013 market close price ($12.15), and this net amount ($1.55) was then multiplied by the number of options (12,000), with the resulting amount then divided by the market close price to result in a net issuance of 1,531 shares to the optionee. The 10,469 shares underlying the remaining portion of the options are not available for reissuance, and no shares are sold into the market as part of the exercise in connection with a net issuance program.
1,531 shares are held directly by the Reporting Person; 1,000 shares are held indirectly by The Mitchell Living Trust
Margaret E. Valeur-Jensen, By Power of Attorney
2013-04-01